Scarica l'app Stockscreener
0.8712
9.65%
-0.0931
Pre-mercato:
.89
0.0188
+2.16%
Precedente Chiudi:
$0.9643
Aprire:
$0.982
Volume 24 ore:
2.21M
Relative Volume:
1.03
Capitalizzazione di mercato:
$59.85M
Reddito:
$3.67M
Utile/perdita netta:
$-13.83M
Rapporto P/E:
-3.1114
EPS:
-0.28
Flusso di cassa netto:
$-10.79M
1 W Prestazione:
-9.63%
1M Prestazione:
-12.88%
6M Prestazione:
-24.24%
1 anno Prestazione:
+52.82%
Intervallo 1D:
$0.8711
$0.982
Intervallo di 1 settimana:
$0.8711
$1.10
Portata 52W:
$0.5101
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Nome
Icecure Medical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ICCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.8712 | 66.49M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Icecure Medical Ltd Borsa (ICCM) Ultime notizie
Pattern recognition hints at IceCure Medical Ltd upsideNew Guidance & Free Accurate Trade Setup Notifications - newser.com
New FDA-Approved Breast Cancer Treatment Freezes Tumors Instead Of Removing Them - essence.com
Brookline Capital Management Predicts IceCure Medical Q3 Earnings - MarketBeat
IceCure Medical to Attend the 2025 Maxim Growth Summit - Stock Titan
IceCure Medical (NASDAQ:ICCM) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
IceCure Medical : Company Presentation - MarketScreener
FDA Authorizes ProSense Cryoablation System for Early-Stage Breast Cancer in Older Women - Medical Dialogues
IceCure Medical (NASDAQ:ICCM) Price Target Raised to $2.50 - MarketBeat
HC Wainwright & Co. Maintains IceCure Medical (ICCM) Buy Recommendation - Nasdaq
IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright - Investing.com
IceCure Medical price target raised to $2.50 from $2 at H.C. Wainwright - TipRanks
ICCM: HC Wainwright & Co. Boosts Price Target to $2.50, Maintains Buy Rating | ICCM Stock News - GuruFocus
IceCure ProSense Cryoablation Receives FDA Marketing Authorization for Treating Low-Risk Breast Cancer in Women Aged 70+ - Imaging Technology News
Icecure gets FDA nod for Prosense cryoablation in breast cancer - BioWorld MedTech
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment - Yahoo Finance
Transcript : IceCure Medical LtdSpecial Call - MarketScreener
What MACD and RSI say about IceCure Medical Ltd2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
Chart based exit strategy for IceCure Medical LtdJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
IceCure Medical Ltd’s volatility index tracking explained2025 Valuation Update & Growth-Oriented Investment Plans - newser.com
IceCure Medical Ltd stock prediction for this weekMarket Performance Recap & Reliable Breakout Forecasts - newser.com
What drives EcoSynthetix Inc 0Y8 stock priceStock Split Announcements & Rapid Wealth Building Tips - earlytimes.in
IceCure Medical Ltd Stock Analysis and ForecastPrice-to-Book Ratio Updates & Your Free Entry to Smart Investing Starts Here - earlytimes.in
IceCure Receives FDA Marketing Authorization for ProSense(R) Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above - MarketScreener
Using portfolio simulators with IceCure Medical Ltd includedJuly 2025 Retail & Safe Capital Investment Plans - newser.com
Key metrics from IceCure Medical Ltd’s quarterly dataQuarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com
Developing predictive dashboards with IceCure Medical Ltd data2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
Is IceCure Medical Ltd stock attractive for growth ETFsPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
IceCure Medical Ltd. (NASDAQ:ICCM) Short Interest Down 49.8% in September - MarketBeat
IceCure Medical Surges on FDA Authorization for Breast Cancer Treatment - StocksToTrade
IceCure Medical Ltd. (NASDAQ:ICCM) Receives Average Rating of "Buy" from Analysts - MarketBeat
IceCure Medical Ltd. Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above - MarketScreener
FDA approves IceCure cryoablation for breast cancer - MassDevice
IceCure Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above - Lelezard
IceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care - Lelezard
ICCM Gains FDA Approval for ProSense Cryoablation System in Cert - GuruFocus
IceCure Receives FDA Marketing Authorization for ProSense® Cryoa - GuruFocus
Icecure Medical stock surges after FDA approves breast cancer treatment - Investing.com
IceCure Medical Gets FDA Approval for ProSense Breast Cancer Treatment; Shares Rise - MarketScreener
IceCure Medical receives FDA marketing authorizationf or ProSense cryoablation - TipRanks
Full technical analysis of IceCure Medical Ltd stock2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
46,000 U.S. Women: IceCure Receives FDA Marketing Authorization for ProSense®; CPT III Covers $3,800 - Stock Titan
Detecting price anomalies in IceCure Medical Ltd with AILong Setup & Low Risk High Win Rate Picks - newser.com
Visualizing IceCure Medical Ltd stock with heatmapsJuly 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
Icecure's Prosense At the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer - MarketScreener
IceCure's ProSense® at the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer, Positive Results from 5 Independent Studies Presented - Barchart.com
IceCure Medical Ltd stock trendline breakdownJuly 2025 Retail & Verified Momentum Stock Watchlist - newser.com
Icecure Medical Ltd Azioni (ICCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):